Inventor · disambiguated record
Liang Chen
Also filed as: CHEN LIANG · CHEN LIANG-YU
6 granted patents·11 pending applications·451 citations·filing 2003–2024
86Inventor score
Top patents by PatentIndex Score
17 records- 0198US7517903B2Cytotoxic compounds and conjugatesMEDAREX INC·Filed 2005·Granted Apr 14, 2009·161 cites·19 claims
- 0296US7691962B2Chemical linkers and conjugates thereofMEDAREX INC·Filed 2005·Granted Apr 6, 2010·200 cites·47 claims
- 0393US8461117B2Chemical linkers and cleavable substrates and conjugates thereofSUFI BILAL·Filed 2007·Granted Jun 11, 2013·61 cites·9 claims
- 0492US8664407B2Chemical linkers with single amino acids and conjugates thereofCHEN LIANG·Filed 2008·Granted Mar 4, 2014·26 cites·7 claims
- 0571US8399403B2Chemical linkers and conjugates thereofBOYD SHARON E·Filed 2009·Granted Mar 19, 2013·2 cites·13 claims
- 0668US2025115617A1Macrocyclic cyclophanesUNIV IOWA STATE RES FOUND INC·Filed 2024·Application pending·0 cites
- 0757US2025283070A1Method for screening alpha beta-tcr heterodimer mutantsLIYANG TCR BIOTHERAPEUTICS CO LTD·Filed 2021·Application pending·0 cites
- 0857US2022364072A1Fusion protein that improves gene editing efficiency and application thereofUNIV EAST CHINA NORMAL·Filed 2022·Application pending·0 cites
- 0956US2025250586A1Base Editing System for Achieving A-To-C and/or A-To-T Base Mutations and Use ThereofUNIV EAST CHINA NORMAL·Filed 2021·Application pending·0 cites
- 1054US7323496B2Compounds for treatment of inflammation, diabetes and related disordersTHERACOS INC·Filed 2003·Granted Jan 29, 2008·1 cites·17 claims
- 1151US2022275045A1High affinity t-cell receptor capable of identifying ny-eso-1 antigenXLIFESC LTD·Filed 2020·Application pending·0 cites
- 1247US2008188654A1Compounds for treatment of inflammation, diabetes and related disordersTHERACOS INC·Filed 2007·Application pending·0 cites
- 1344US2007093524A15-Lipoxygenase modulatorsWYETH CORP·Filed 2006·Application pending·0 cites
- 1443US2008279868A1Antibody-Drug Conjugates and Methods of UseMEDAREX INC·Filed 2006·Application pending·0 cites
- 1539US2020347407A1Split single-base gene editing systems and application thereofUNIV EAST CHINA NORMAL·Filed 2018·Application pending·0 cites
- 1637US2008108825A1Compounds for treatment of inflammation, diabetes and related disordersTHERACOS INC·Filed 2007·Application pending·0 cites
- 1737US2008103302A1Compounds for treatment of inflammation, diabetes and related disordersTHERACOS INC·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Liang Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →